U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.


Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Drug Enforcement Administration

New Jersey

Susan A. Gibson, Special Agent in Charge

February 24, 2021

Contact: Timothy P. McMahon

Phone Number: (973) 776-1143

Four Defendants Arrested on Charges They Conspired to Illegally Obtain and Distribute Oxycodone Out of a Pharmacy in Warren County

Former Pharmacist-in-Charge at Panther Valley Pharmacy in Allamuchy, N.J., among those charged

TRENTON, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and Attorney General for the State of New Jersey Gurbir S. Grewal today announced the arrests of four individuals, including the former registered pharmacist-in-charge, who allegedly conspired to illegally obtain and distribute the highly addictive opioid painkiller oxycodone out of Panther Valley Pharmacy in Allamuchy, N.J. It is alleged, based on prescription records, that more than 30,000 high-dose 30 milligram oxycodone pills – known as “blues” – were illegally diverted from the pharmacy through the criminal scheme. 

The following defendants were arrested and charged with Conspiracy (2nd Degree), Distribution of a Controlled Dangerous Substance (CDS) (Oxycodone, 2nd Degree), and Distribution of a CDS (Promethazine, 4th Degree):

  • Anny Chan, 51, of Clinton, N.J., formerly the registered pharmacist-in-charge at Panther Valley Pharmacy
  • Milagros Santiago, 43, of Haledon, N.J.
  • Jonathan Miller, 34, of Whippany, N.J.
  • Siraj Vickers, 39, of Tobyhanna, Pa

In addition, Santiago is charged with Theft by Unlawful Taking (3rd Degree), and Santiago, Miller and Vickers are charged with Falsifying Medical Records (4th Degree) and Falsifying or Tampering with Records (4th Degree). The arrests were made between February 9 and yesterday, February 23.
The charges resulted from an investigation by the Division of Criminal Justice Gangs & Organized Crime Bureau, the New Jersey Division of Consumer Affairs’ Enforcement Bureau, and the U.S. Drug Enforcement Administration’s New Jersey Tactical Diversion Squad in Newark. The Monmouth County Medical Examiner’s Office also provided critical assistance. In February 2020, Chan entered a consent order with the State Board of Pharmacy to voluntarily surrender her pharmacy license, to be deemed a temporary suspension, pending further action by the Board.
“Unfortunately, we see too often how prescription opioid abuse and addiction can lead to the transition to heroin and fentanyl use and overdose,” said Special Agent in Charge of the DEA’s New Jersey Division Susan A. Gibson. “These defendants seek to profit on the pain and suffering of those addicted to prescription opioids, and every pill they sell can be one step closer to death to those that need help the most. We will continue to pursue those who choose to violate the law, especially those in the medical and pharmacy community who choose to violate their oaths.”
“Oxycodone has long been the gateway drug for the opioid epidemic, which is claiming so many lives in New Jersey and across the nation,” said Attorney General Grewal. “We will continue to prosecute the licensed professionals and other criminals who divert these opioid pills into our communities and cause so much addiction, misery and death, either directly through pill overdoses or by leading users to the cheaper and deadlier alternatives of heroin and fentanyl.”
“Prescription drug abuse is a major driver of opioid addiction, and we will continue to work with our law enforcement partners to combat the diversion of these dangerous drugs into our communities,” said Director Veronica Allende of the Division of Criminal Justice. “I want to thank the Division of Consumer Affairs Enforcement Bureau, which provided substantial assistance in analyzing prescription records, including data from the New Jersey Prescription Monitoring Program database, the DEA, and the Monmouth County Medical Examiner’s Office, which helped initiate the investigation.”
The New Jersey Prescription Monitoring Program (NJPMP), operated within the Division of Consumer Affairs, is an electronic database that collects information from pharmacies on the dispensing of CDS – including opioids – to individual patients. It creates a record for the patient so that healthcare providers can understand a patient’s full prescription drug history. The tool aims to improve prescribing practices, target treatment to at-risk patients, and mitigate the risk of potential abuse or fraud by patients who obtain prescriptions from multiple providers.
“Battling New Jersey’s opioid epidemic is a top priority for the Division of Consumer Affairs, and the NJPMP is one of our most powerful tools in that fight,” said Kaitlin A. Caruso, Acting Director of the Division of Consumer Affairs. “In this case, information from the database revealed suspicious activity that, upon further investigation, uncovered the criminal activity that led to these charges. We are proud of the role our PMP and our Enforcement Bureau played in shutting down this dangerous illegal prescription drug enterprise.”
In September 2019, the investigating agencies received information from the Monmouth County Medical Examiner’s Office about suspicious activity at Panther Valley Pharmacy in Allamuchy, which included oxycodone prescriptions being filled for a deceased individual up to a year after his death, and a drastic spike in the number of CDS dosage units being dispensed.
The investigation, including the execution of a court authorized search warrant on the pharmacy on Nov. 7, 2019, revealed that Miller, Chan, Santiago, Vickers, and others allegedly conspired during the months of April 2018 through approximately October 2019 to illegally obtain and distribute oxycodone and promethazine by removing the CDS from the pharmacy under the guise of falsified New Jersey prescription blanks. The prescription blanks were allegedly unlawfully taken from St. Joseph’s University Medical Center in Paterson, N.J., and Holy Name Medical Center in Teaneck, N.J.
During the search of the pharmacy, approximately 167 falsified oxycodone prescriptions that ranged in date from April 27, 2018 to September 26, 2019 were recovered, as well as records and electronic devices.  Subsequent review of seized cellphones revealed communications between a pharmacy technician and Miller, Santiago and Vickers. The communications showed that Miller and Vickers allegedly purchased the oxycodone and promethazine removed from the pharmacy and participated in the falsification of the prescriptions. Santiago, a pharmacy technician at St. Joseph’s Medical Center, allegedly stole prescription blanks that were used to falsify the prescriptions to cover the illegal distribution of CDS from the pharmacy. Chan allegedly agreed to allow illegitimate prescriptions to be filled in the pharmacy in exchange for payment.
Attorney General Grewal thanked the Division of Consumer Affairs Enforcement Bureau and the DEA’s New Jersey Tactical Diversion Squad for their valuable assistance.
21-13                                                                  ###

DEA US Badge
United States Drug Enforcement Administration DEA.gov is an official site of the U.S. Department of Justice